Literature DB >> 16344131

Sonic activation of molecularly-targeted nanoparticles accelerates transmembrane lipid delivery to cancer cells through contact-mediated mechanisms: implications for enhanced local drug delivery.

Kathryn C Crowder1, Michael S Hughes, Jon N Marsh, Alejandro M Barbieri, Ralph W Fuhrhop, Gregory M Lanza, Samuel A Wickline.   

Abstract

Liquid perfluorocarbon nanoparticles serve as sensitive and specific targeted contrast and drug delivery vehicles by binding to specific cell surface markers. We hypothesized that application of acoustic energy at diagnostic power levels could promote nanoparticle-associated drug delivery by stimulating increased interaction between the nanoparticle's lipid layer and the targeted cell's plasma membrane. Ultrasound (mechanical index = 1.9) applied with a conventional ultrasound imaging system to nanoparticles targeted to alpha(v)beta3-integrins on C32 melanoma cancer cells in vitro produced no untoward effects. Within 5 min, lipid delivery from nanoparticles into cell cytoplasm was dramatically augmented. We also demonstrate the operation of a potential physical mechanism for this effect, the acoustic radiation force on the nanoparticles, which may contribute to the enhanced lipid delivery. Accordingly, we propose that local delivery of lipophilic substances (e.g., drugs) from targeted nanoparticles directly into cell cytoplasm can be augmented rapidly and safely with conventional ultrasound imaging devices through nondestructive mechanisms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16344131     DOI: 10.1016/j.ultrasmedbio.2005.07.022

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  19 in total

1.  Targeting therapy of choroidal neovascularization by use of polypeptide- and PEDF-loaded immunoliposomes under ultrasound exposure.

Authors:  Tao Li; Ming Zhang; Yong Han; Hong Zhang; Lingjuan Xu; Yan Xiang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-12-22

2.  Application of ultrasound to selectively localize nanodroplets for targeted imaging and therapy.

Authors:  Paul A Dayton; Shukui Zhao; Susannah H Bloch; Pat Schumann; Kim Penrose; Terry O Matsunaga; Reena Zutshi; Alexander Doinikov; Katherine W Ferrara
Journal:  Mol Imaging       Date:  2006-07       Impact factor: 4.488

3.  New mechanisms for non-porative ultrasound stimulation of cargo delivery to cell cytosol with targeted perfluorocarbon nanoparticles.

Authors:  Nr Soman; Jn Marsh; Gm Lanza; Sa Wickline
Journal:  Nanotechnology       Date:  2008-05-07       Impact factor: 3.874

Review 4.  Cardiovascular therapeutic uses of targeted ultrasound contrast agents.

Authors:  Susan T Laing; David D McPherson
Journal:  Cardiovasc Res       Date:  2009-07-06       Impact factor: 10.787

5.  Exploiting lipid raft transport with membrane targeted nanoparticles: a strategy for cytosolic drug delivery.

Authors:  Kathryn C Partlow; Gregory M Lanza; Samuel A Wickline
Journal:  Biomaterials       Date:  2008-05-16       Impact factor: 12.479

Review 6.  Nanomedicine strategies for molecular targets with MRI and optical imaging.

Authors:  Dipanjan Pan; Shelton D Caruthers; Junjie Chen; Patrick M Winter; Angana SenPan; Anne H Schmieder; Samuel A Wickline; Gregory M Lanza
Journal:  Future Med Chem       Date:  2010-03       Impact factor: 3.808

7.  MR molecular imaging of angiogenesis using targeted perfluorocarbon nanoparticles.

Authors:  S D Caruthers; P M Winter; S A Wickline; G M Lanza; J Keupp
Journal:  Medicamundi       Date:  2010

8.  Formulation and characterization of echogenic lipid-Pluronic nanobubbles.

Authors:  Tianyi M Krupka; Luis Solorio; Robin E Wilson; Hanping Wu; Nami Azar; Agata A Exner
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

Review 9.  Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics.

Authors:  Megan M Kaneda; Shelton Caruthers; Gregory M Lanza; Samuel A Wickline
Journal:  Ann Biomed Eng       Date:  2009-01-30       Impact factor: 3.934

10.  Minute dosages of alpha(nu)beta3-targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbits.

Authors:  Patrick M Winter; Anne H Schmieder; Shelton D Caruthers; Jeffery L Keene; Huiying Zhang; Samuel A Wickline; Gregory M Lanza
Journal:  FASEB J       Date:  2008-03-24       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.